| Product dosage: 120mg | |||
|---|---|---|---|
| Package (num) | Per cap | Price | Buy |
| 30 | $4.52 | $135.45 (0%) | 🛒 Add to cart |
| 60 | $4.05 | $270.91 $242.82 (10%) | 🛒 Add to cart |
| 90 | $3.88 | $406.36 $349.17 (14%) | 🛒 Add to cart |
| 120 | $3.80
Best per cap | $541.82 $456.53 (16%) | 🛒 Add to cart |
| Product dosage: 60mg | |||
|---|---|---|---|
| Package (num) | Per cap | Price | Buy |
| 30 | $1.97 | $59.20 (0%) | 🛒 Add to cart |
| 60 | $1.54 | $118.40 $92.31 (22%) | 🛒 Add to cart |
| 90 | $1.39 | $177.60 $125.42 (29%) | 🛒 Add to cart |
| 120 | $1.31 | $236.80 $157.53 (33%) | 🛒 Add to cart |
| 180 | $1.24 | $355.19 $223.75 (37%) | 🛒 Add to cart |
| 270 | $1.20 | $532.79 $323.09 (39%) | 🛒 Add to cart |
| 360 | $1.17
Best per cap | $710.39 $421.42 (41%) | 🛒 Add to cart |
Synonyms | |||
More info:
orlistat
Orlistat is a gastrointestinal lipase inhibitor used as a weight management agent in conjunction with a reduced-calorie diet. It works locally in the gut to block the absorption of about 25% of dietary fat by inhibiting pancreatic and gastric lipases. Marketed under brand names like Xenical (120mg prescription) and Alli (60mg over-the-counter), it represents one of the few evidence-based pharmacological options for chronic weight management. Unlike central-acting appetite suppressants, orlistat’s peripheral mechanism offers a different risk-benefit profile that’s been studied in outcomes ranging from diabetes prevention to cardiovascular risk reduction.
alli
Orlistat, marketed under the brand name alli, represents one of the few FDA-approved weight loss aids available over-the-counter. As a gastrointestinal lipase inhibitor, it works locally in the gut to block absorption of dietary fat by about 25%. We’ve been using prescription-strength orlistat (Xenical) for decades, but the 60mg OTC version opened up access while maintaining the same mechanism of action. What’s fascinating is how this simple concept - preventing fat absorption rather than suppressing appetite - created both clinical benefits and very specific management challenges.
mysimba
Mysimba represents one of the more interesting pharmacological approaches to weight management we’ve seen in recent years. It’s not a single-agent drug but rather a fixed-dose combination product containing naltrexone HCl and bupropion HCl in an extended-release formulation. What’s fascinating clinically is how it leverages established neurobiological pathways—the same ones we target in addiction medicine—for weight loss. I remember when our endocrinology department first started prescribing it back in 2017, there was considerable skepticism about repurposing these particular medications.
Xenical: Clinically Proven Weight Management Aid - Evidence-Based Review
Orlistat, marketed as Xenical, represents one of the few FDA-approved pharmacological interventions for chronic weight management that operates through a non-systemic mechanism. Unlike appetite suppressants or metabolic accelerators, this lipase inhibitor works locally in the gastrointestinal tract to block dietary fat absorption by approximately 30%. I first encountered Xenical during my residency when our endocrinology department initiated a comprehensive weight management program, and we quickly discovered its unique position in our therapeutic arsenal—particularly for patients who had failed multiple dietary interventions yet remained hesitant about bariatric surgery.
abana
Product Description Abana represents one of those formulations that initially puzzled me when I first encountered it in practice - a comprehensive herbal supplement with roots in Ayurvedic medicine, primarily indicated for cardiovascular support. What struck me during my early years at the Cleveland Clinic was how this multi-herb preparation kept appearing in patients’ medication lists, particularly among those with familial hyperlipidemia patterns. The formulation contains a sophisticated blend of Terminalia arjuna, Inula racemosa, Commiphora mukul, and several other botanicals that work synergistically - something we rarely see in single-component pharmaceuticals.
abhigra
Product Description: Abhigra represents a novel class of medical-grade nutraceutical devices that combines standardized botanical extracts with a patented sublingual delivery system. Unlike conventional supplements, its mechanism relies on transmucosal absorption bypassing first-pass metabolism, which we’ve observed yields significantly faster onset of action—particularly valuable for acute inflammatory episodes. The development team spent three years battling stability issues with the nanoemulsion matrix before discovering that alternating temperature cycles during production actually enhanced bioactive preservation, contrary to our initial assumptions.
abilify
Aripiprazole, marketed under the brand name Abilify, represents a significant advancement in psychopharmacology as a second-generation antipsychotic medication. Unlike first-generation antipsychotics that primarily function as dopamine D2 receptor antagonists, aripiprazole exhibits a unique mechanism as a partial dopamine agonist. This pharmacological profile allows it to stabilize dopamine activity rather than simply blocking it, creating what many clinicians describe as a “dopamine stabilizer” effect. The medication has received FDA approval for multiple psychiatric conditions including schizophrenia, bipolar disorder, major depressive disorder (as adjunct treatment), Tourette’s disorder, and irritability associated with autistic disorder.
Acamprol: Targeted Neurological Support for Hyperexcitability Disorders - Evidence-Based Review
In my early neurology practice, we kept hitting walls with certain patients—the ones with persistent neurological irritability where standard GABAergics either failed or caused unacceptable sedation. That’s when our hospital’s pharmacology team first showed me the molecular structure of what would become Acamprol. It wasn’t another benzodiazepine analog or some exotic plant extract, but a synthetic compound mimicking taurine’s neuromodulatory properties. We initially called it “Calcium Acetylhomotaurinate” until the brand name stuck.
Accufine: Advanced Continuous Glucose Monitoring for Diabetes Management - Evidence-Based Review
Product Description: Accufine represents a significant advancement in non-invasive glucose monitoring technology. It’s a continuous glucose monitoring (CGM) system that uses micro-needle sensor technology combined with advanced algorithms to provide real-time interstitial fluid glucose readings without the traditional fingerstick calibration. The device consists of a discreet wearable sensor that transmits data to both a dedicated reader and compatible smartphone applications, allowing for comprehensive glucose trend analysis and predictive alerts. I remember when we first started developing this technology back in 2018 - our team was divided between pursuing traditional electrochemical sensing versus this novel optical approach.